HSIC vs NDRA · P/E 24, rev $12.67B vs P/E 0.0, $2.6M cap
Henry Schein Inc (HSIC) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
NDRA does not have a complete income-statement cache yet.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the HSIC and NDRA stock pages for the full models.
Not investment advice.